Abstract
Serotonin type 2 (5-HT 2) receptors reportedly inhibit neuropathic pain in the spinal cord, but little is known about how spinal 5-HT 2 receptors might act against such abnormal sensitivity. We examined whether the cholinergic and tachykinin systems were involved in the antiallodynic effect of intrathecally administered 5-HT 2 receptor agonists in rats with nerve injury. Allodynia was produced by tight ligation of the left L5 and L6 spinal nerves, and determined by applying von Frey hairs to the left hindpaw. Effects of intrathecal pretreatment with 5-HT 2 receptor antagonists (ketanserin and RS-102221), muscarinic receptor antagonists (atropine and scopolamine), a choline uptake blocker (hemicholium-3), and an NK 1 receptor antagonist (L-706336) were assessed in rats subsequently given a 100-μg intrathecal dose of a 5-HT 2 receptor agonist either α-methyl-5-HT or iododimethoxy aminopropane (DOI). Antiallodynic effects of 5-HT 2 receptor agonists were attenuated by the 5-HT 2A receptor antagonist ketanserin (30 μg), but not by the 5-HT 2C receptor antagonist RS-102221 (40 μg). Muscarinic receptor antagonists (30 μg each), the choline uptake blocker (10 μg), and the NK 1 receptor antagonist (30 μg) also inhibited the antiallodynic effects of 5-HT 2 receptor agonists. Antiallodynic effects of intrathecally administered 5-HT 2 receptor agonists may be mediated by spinal release of acetylcholine induced via 5-HT 2A and NK 1 receptors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
